SPIMACO
2070TASIPharmaBiotech & Life Science
29.76SAR(0.70) (2.30%)
- Open
- 30.46
- High
- 30.86
- Low
- 29.60
- Prev. close
- 30.46
- Volume
- 0.35M
- Value
- 10.58M
- Trades
- 1,235
2070TASIPharmaBiotech & Life Science
| Item | 2025 | Change |
|---|---|---|
| Total revenue | 1,706.71 | 1.47% |
| Gross profit | 832.55 | (8.14%) |
| Operating income | 247.87 | 80.33% |
| Net income | 184.36 | 651.43% |
| Item | 2025 | Change |
|---|---|---|
| Total assets | 4,367.75 | — |
| Total liabilities | 2,605.59 | — |
| Total debt | 1,434.29 | (5.17%) |
| Shareholders’ equity | 1,762.16 | — |
| Item | 2025 | Change |
|---|---|---|
| Operating cash flow | 272.35 | 182.29% |
| Investing cash flow | (85.01) | (78.69%) |
| Financing cash flow | — | — |
| Free cash flow | — | — |